Effect of Remote Cognitive Intervention in Patients With Parkinson's Disease During the COVID-19 Pandemic (TELEPARK)

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Completed

Conditions

COVID-19
Mild Cognitive Impairment
Parkinson Disease

Treatments

Other: Cognitive digital treatment

Study type

Observational

Funder types

Other

Identifiers

NCT05476302
INRCA_004_2022

Details and patient eligibility

About

Retrospective study to evaluate the effect of a remote cognitive-rehabilitative intervention during the Covid outbreak in subjects with Parkinson's disease.

Full description

Mild cognitive impairment is frequent among people with Parkinson's disease. Cognitive training seems effective on cognitive status and for mitigating anxiety and depression. With COVID-19 outbreak, such therapeutic interventions were delivered online. This retrospective study was aimed at evaluating the effectiveness of an online cognitive treatment, carried out in COVID times and based on the Parkinson's-Adapted Cognitive Stimulation Therapy, on cognitive domains and mood in 18 older people with Parkinson's disease.

Enrollment

18 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Parkinson disease: Hoehn & Yahr's scale: 1-3 based on the UK PD Society Brain Bank mild cognitive impairment no cognitive training between March and October 2020 presence of a family caregiver to access and use the online platform

Exclusion criteria

other neurological diseases deep brain stimulation schizophrenia depression sensory deprivations that could interfere with the treatment

Trial design

18 participants in 1 patient group

Cognitive digital treatment
Description:
Cognitive digital treatment in patients with Parkinson's disease
Treatment:
Other: Cognitive digital treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems